130 related articles for article (PubMed ID: 11493755)
21. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.
O-Charoenrat P; Rhys-Evans PH; Eccles SA
Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):813-20. PubMed ID: 11448356
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer.
Shim KN; Jung SA; Joo YH; Yoo K
J Gastroenterol; 2007 Feb; 42(2):120-8. PubMed ID: 17351800
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.
Huang LW; Garrett AP; Bell DA; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2000 Jun; 77(3):369-76. PubMed ID: 10831344
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinases and their inhibitors in malignant and autoreactive pericardial effusion.
Lamparter S; Schoppet M; Christ M; Pankuweit S; Maisch B
Am J Cardiol; 2005 May; 95(9):1065-9. PubMed ID: 15842972
[TBL] [Abstract][Full Text] [Related]
26. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
Hoheisel G; Sack U; Hui DS; Huse K; Chan KS; Chan KK; Hartwig K; Schuster E; Scholz GH; Schauer J
Tuberculosis (Edinb); 2001; 81(3):203-9. PubMed ID: 11466032
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinases and their inhibitors in the cervical mucus plug at term of pregnancy.
Becher N; Hein M; Danielsen CC; Uldbjerg N
Am J Obstet Gynecol; 2004 Oct; 191(4):1232-9. PubMed ID: 15507946
[TBL] [Abstract][Full Text] [Related]
28. Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Romanini C; Biagini G
Anticancer Res; 1996; 16(4A):2123-7. PubMed ID: 8712754
[TBL] [Abstract][Full Text] [Related]
29. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
Kikkawa F
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829
[TBL] [Abstract][Full Text] [Related]
30. Calcifying Cystic Odontogenic Tumour: immunohistochemical expression of matrix metalloproteinases, their inhibitors (TIMPs and RECK) and inducer (EMMPRIN).
Prosdócimi FC; Rodini CO; Sogayar MC; Sousa SC; Xavier FC; Paiva KB
J Oral Pathol Med; 2014 Aug; 43(7):545-53. PubMed ID: 24484176
[TBL] [Abstract][Full Text] [Related]
31. Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease.
Rosemar A; Ivarsson ML; Börjesson L; Holmdahl L
Scand J Gastroenterol; 2007 Feb; 42(2):215-20. PubMed ID: 17327941
[TBL] [Abstract][Full Text] [Related]
32. Collagenolytic fragments and active gelatinase complexes in periodontitis.
Bildt MM; Bloemen M; Kuijpers-Jagtman AM; Von den Hoff JW
J Periodontol; 2008 Sep; 79(9):1704-11. PubMed ID: 18771372
[TBL] [Abstract][Full Text] [Related]
33. Clinical Investigation of Matrix Metalloproteinases, Tissue Inhibitors of Matrix Metalloproteinases, and Matrix Metalloproteinase/Tissue Inhibitors of Matrix Metalloproteinase Complexes and Their Networks in Apical Periodontitis.
Martinho FC; Teixeira FF; Cardoso FG; Ferreira NS; Nascimento GG; Carvalho CA; Valera MC
J Endod; 2016 Jul; 42(7):1082-8. PubMed ID: 27188765
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patients.
Pozo P; Valenzuela MA; Melej C; Zaldívar M; Puente J; Martínez B; Gamonal J
J Periodontal Res; 2005 Jun; 40(3):199-207. PubMed ID: 15853964
[TBL] [Abstract][Full Text] [Related]
35. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma.
Adithi M; Nalini V; Kandalam M; Krishnakumar S
J Pediatr Hematol Oncol; 2007 Jun; 29(6):399-405. PubMed ID: 17551402
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in gingival crevicular fluid during orthodontic tooth movement.
Bildt MM; Bloemen M; Kuijpers-Jagtman AM; Von den Hoff JW
Eur J Orthod; 2009 Oct; 31(5):529-35. PubMed ID: 19299245
[TBL] [Abstract][Full Text] [Related]
37. Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with HIV-1 infection and syphilis or neurosyphilis.
Tsai HC; Ye SY; Kunin CM; Lee SS; Wann SR; Tai MH; Shi MH; Liu YC; Chen YS
Cytokine; 2011 May; 54(2):109-16. PubMed ID: 21354815
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
Hu J; Zhang X; Nothnick WB; Spencer TE
Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
[TBL] [Abstract][Full Text] [Related]
39. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.
Kayano K; Shimada T; Shinomiya T; Nakai S; Hisa Y; Aoki T; Seiki M; Okada Y
J Pathol; 2004 Apr; 202(4):403-11. PubMed ID: 15095267
[TBL] [Abstract][Full Text] [Related]
40. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]